Archives202520242023202220212020201920182017201620152014201320122011 December 03, 2020ImmuPharma to present at Biotech Showcase™ Digital 2021 Read More November 30, 2020Total Share Capital Notification Read More November 26, 2020Grant of Share Options & PDMR dealing Read More November 24, 2020Conversion of Convertible Security Read More November 23, 2020Conversion of Convertible Security Read More November 20, 2020FDA confirms 4 December 2020 for Type ‘A’ meeting to discuss guidance on forthcoming international Phase 3 trial of Lupuzor™ in Lupus patients Read More November 19, 2020Total Share Capital Notification Read More November 10, 2020Update on submission to the FDA for the forthcoming international Phase 3 trial of Lupuzor™ in Lupus patients Read More September 30, 2020Total Share Capital Notification Admission to trading on Euronext Growth Brussels of newly issued ordinary shares Read More September 30, 2020INTERIM RESULTS ANNOUNCEMENT for the six months ended 30 June 2020 Read More September 29, 2020Share Subscription into Incanthera plc (“Incanthera”) Read More September 22, 2020Repayment of Convertible Security – Lind Global Macro Fund, LP Read More 1234
November 20, 2020FDA confirms 4 December 2020 for Type ‘A’ meeting to discuss guidance on forthcoming international Phase 3 trial of Lupuzor™ in Lupus patients Read More
November 10, 2020Update on submission to the FDA for the forthcoming international Phase 3 trial of Lupuzor™ in Lupus patients Read More
September 30, 2020Total Share Capital Notification Admission to trading on Euronext Growth Brussels of newly issued ordinary shares Read More
